Arrowhead Pharmaceuticals, Inc.
ARWR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000879407
In the last 90 days, Arrowhead Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 2 sales; 501 institutions reported holding it in 13F filings for Q2 2026, worth $9.73B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Arrowhead Pharmaceuticals, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 281
- +19 vs. Q1 2025
- Shares held
- 105.8M
- +531.3K (+0.5%) vs. Q1 2025
- Total value
- $1.67B
- +$329.9M (+24.6%) vs. Q1 2025
- New holders
- 57
- 98 more added
- Sold out
- 38
- 81 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARWR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 501 | $9.73B |
| Q1 2026 | 437 | $7.58B |
| Q4 2025 | 401 | $7.70B |
| Q3 2025 | 303 | $3.83B |
| Q2 2025 | 281 | $1.67B |
| Q1 2025 | 264 | $1.34B |
| Q4 2024 | 269 | $1.88B |
| Q3 2024 | 272 | $1.90B |
| Q2 2024 | 272 | $2.54B |
| Q1 2024 | 273 | $2.76B |
| Q4 2023 | 266 | $2.37B |
| Q3 2023 | 257 | $2.01B |
| Q2 2023 | 274 | $2.57B |
| Q1 2023 | 257 | $1.85B |
| Q4 2022 | 282 | $2.97B |
| Q3 2022 | 278 | $2.35B |
| Q2 2022 | 279 | $2.54B |
| Q1 2022 | 307 | $3.19B |
| Q4 2021 | 311 | $4.51B |
| Q3 2021 | 297 | $4.16B |
| Q2 2021 | 314 | $5.54B |
| Q1 2021 | 289 | $4.55B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Arrowhead Pharmaceuticals, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 0 | $0 | 0.00% | −13,622−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −13,850−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −13,158−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Gratus Wealth Advisors, LLC | 0 | $0 | 0.00% | −12,250−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,421−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −3,190−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −2,380−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1,300−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −511−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −473−100.0% | Sold out |
| High Note Wealth, LLC | 0 | $0 | 0.00% | −209−100.0% | Sold out |
| Stonebridge Financial Group, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| UMA Financial Services, Inc. | 0 | $0 | 0.00% | −68−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| JFS Wealth Advisors, LLC | 0 | $0 | 0.00% | −39−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Bokf, NA | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Buffington Mohr McNeal | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |